What are the typical dosages of alpha-blockers (e.g. phenoxybenzamine, doxazosin, prazosin) and beta-blockers (e.g. propranolol) used in the management of phaeochromocytoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medication Dosages for Pheochromocytoma Management

Alpha-Blockers (First-Line Preoperative Treatment)

Alpha-adrenergic blockade must be initiated at least 7-14 days before any surgical or therapeutic intervention, with gradual dose escalation until blood pressure targets are achieved: <130/80 mmHg supine AND systolic >90 mmHg standing. 1, 2

Phenoxybenzamine (Non-selective, Non-competitive Alpha Blocker)

  • Starting dose: 10 mg orally twice daily 3
  • Titration: Increase every other day (every 2-4 days) 1, 3
  • Target dose: 20-40 mg orally 2-3 times daily 1, 3
  • Mechanism advantage: Provides less intraoperative hemodynamic instability compared to selective alpha-blockers, based on the PRESCRIPT trial 1
  • Key caveat: Long-term use is not recommended due to carcinogenicity concerns; causes more pronounced postoperative hypotension and side effects (orthostatic hypotension, edema, nasal congestion) 3, 4

Doxazosin (Selective Alpha-1 Blocker)

  • Starting dose: Begin with low doses and titrate gradually 1
  • Target dose: Titrate to blood pressure goals over 7-14 days 1
  • Advantages: Fewer side effects than phenoxybenzamine, particularly less orthostatic hypotension 4
  • Evidence: Equivalent perioperative safety to phenoxybenzamine in multiple studies, though may require more additional antihypertensive agents 5, 4

Prazosin (Selective Alpha-1 Blocker)

  • Starting dose: 1 mg orally 2-3 times daily 6
  • Titration: Increase slowly to total daily dose of 6-15 mg in divided doses 6
  • Maximum dose: Up to 20-40 mg daily in divided doses if needed 6
  • First-dose effect warning: Significant hypotension can occur 1-2 hours after initial dose (drops of 40-92 mmHg systolic documented); start with 1 mg and monitor closely 7
  • Evidence: Effective in controlling norepinephrine-secreting pheochromocytomas when combined with beta-blockers 7

Terazosin (Selective Alpha-1 Blocker)

  • Dosing: Similar approach to doxazosin and prazosin with gradual titration 1
  • Usage: Listed as acceptable alternative alpha-1 blocker in guidelines 1

Beta-Blockers (Second-Line, Only After Alpha Blockade)

Critical warning: NEVER initiate beta-blockers before adequate alpha blockade—this causes hypertensive crisis from unopposed alpha-adrenergic stimulation. 1, 2, 8

Propranolol (Non-selective Beta Blocker)

  • Indication: Control tachyarrhythmias after alpha blockade is established 3, 7
  • Dosing: 120-480 mg daily in divided doses every 6 hours 7
  • Preference note: Beta-1 selective blockers are preferred over non-selective agents 1

Esmolol (Beta-1 Selective, IV)

  • Loading dose: 500-1000 mcg/kg/min over 1 minute 1
  • Maintenance infusion: 50 mcg/kg/min, increase in 50 mcg/kg/min increments as needed 1
  • Maximum: 200 mcg/kg/min 1
  • Use: Intraoperative tachycardia control 1

Adjunctive Medications

Calcium Channel Blockers

  • Indication: Adjunct to alpha-blockers for refractory hypertension OR monotherapy in patients with normal-to-mildly elevated blood pressure or severe orthostatic hypotension on alpha-blockers 1
  • Example: Nifedipine slow-release formulation 1

Metyrosine

  • Mechanism: Inhibits tyrosine hydroxylase, reducing catecholamine biosynthesis 1
  • Use: Add-on therapy where available for additional catecholamine control 1

Acute Hypertensive Crisis Management (IV Agents)

Phentolamine (Non-selective Alpha Antagonist)

  • Dose: 5 mg IV bolus 1
  • Repeat: Every 10 minutes as needed 1
  • Indication: Hypertensive emergencies from catecholamine excess 1

Labetalol (Combined Alpha-1 and Non-selective Beta Blocker)

  • Dose: 1-2 mg/kg IV twice weekly as bolus over 1 minute, followed by continuous infusion 1
  • Alternative dosing: 0.3-1.0 mg/kg (maximum 20 mg) slow IV injection every 10 minutes OR 0.4-1.0 mg/kg/h infusion up to 3 mg/kg/h 1
  • Maximum cumulative dose: 300 mg, repeatable every 4-6 hours 1
  • Advantage: Allows titration based on blood pressure response and avoids reflex tachycardia 1

Other IV Agents for Intraoperative Hypertension

  • Magnesium sulfate, nitroprusside, nitroglycerin, or calcium antagonists can be used intraoperatively 1

Perioperative Fluid Management

  • High-sodium diet and 1-2 liters of saline 24 hours before surgery to prevent postoperative hypotension 1, 2
  • Compression stockings to reduce orthostatic hypotension risk 1, 2

Special Population: Dopamine-Only Producing Tumors

Do NOT use alpha-blockers for exclusively dopamine-producing pheochromocytomas (isolated plasma methoxytyramine elevation)—these patients are typically normotensive or hypotensive. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initial Treatment for Pheochromocytoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prazosin and propranolol in preoperative management of pheochromocytoma.

Clinical pharmacology and therapeutics, 1982

Research

Case report: pheochromocytoma. Aspects of management.

Anaesthesia and intensive care, 1976

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.